Foot and Mouth Disease Vaccine Market (Conventional Vaccine [Aluminum Hydroxide based vaccine, Oil based vaccines] and Emergency Vaccines) and by Animal Type (Cattle, Swine, Goat and Sheep and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global forecast to 2026

  • Published On : Jul 2018 |
  • Pages : 200 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

FMD Vaccine Market - Shield against Economic Loss

Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both direct and indirect modes. Foot and mouth disease causes high morbidity in animals and results into significant economic loss due to decreased milk productions, permanent hoof damage, and chronic mastitis.

Although adult animals can recover from disease, mortality is high among young animals, as immunity is not well developed due to which foot and mouth disease vaccination is essential. Disease is characterized by the fever and blistery sore on tongue, lips and oral cavity. Foot and mouth disease is best preventable by vaccinating the livestock. There are total seven strains (A, O, C, SAT1, SAT2, SAT3, and Asia1) of virus that affects animals, symptoms produced are similar in each strain and they can be distinguished only through laboratory tests. Various regions around world are affected by different set of viral strain therefore each strain requires specific vaccine to prevent the infection. Inactivated vaccines are available to prevent animals from being infected by FMD

The global foot and mouth disease market size was valued at US$ 1,567 million in 2017, and is expected to witness a CAGR of 9.4% over the forecast period (2018 – 2026).

Figure 1. Global FMD Vaccines Market Value (US$ Mn), by Region, 2017

Foot & Mouth Disease Vaccine  | Coherent Market Insights

Source: Coherent Market Insights (2018)

Repetitive outbreak of FMD in animals negatively affecting economy is driving growth of the foot and mouth disease vaccine

Foot and Mouth Disease (FMD) causes repetitive outbreak around world thereby causing economic and social damage. Preventing foot and mouth disease is the only sustainable and viable options, which can be done only though the vaccination for FMD, which is expected to drive growth of the foot and mouth disease vaccine market. According to paper published by the Food and Agricultural Organization (FAO) and World Organization for Animal Health (OIE), in 2012, foot and mouth disease accounted for annual loss of US$ 5 billion worldwide.

FMB outbreaks affects food industry as it negatively impacts the export of milk, meat, and other animal products due to viral infection. 23 countries from Africa, Asia Pacific, Europe and Middle East reported outbreak of the FMD to the World Organization for Animal Health (OIE) in 2015 - 16. In India, annual loss of more than US$ 85 billion is reported each year due to FMD outbreak, which is negatively affecting dairy sector GDP of India.

Although foot and mouth disease is eradicated from North America and Western Europe, various economies of Asia Pacific, Africa and Latin America witnessed high incidences of epidemic in recent past, which is propelling demand for vaccines against foot and mouth disease in these regions. Various economies such as China, India, Brazil, Thailand etc. are at high risk of FMD outbreak, according to Monthly Report- Foot and Mouth Disease Situation by Food and Agricultural Organization published in February 2018.

However, vaccination against FMD may not prove to be effective by the antigenic diversity of the virus, the short-lived nature of protective immunity developed after vaccination and the temperature sensitivity that alters stability of FMD vaccines, which may restrain growth of the FMD vaccine market.

Figure 2. Revenue Share by Animal Type in FMD Vaccine market, 2017

Foot & Mouth Disease Vaccine  | Coherent Market Insights

Source: Coherent Market Insights (2018)

Increasing number of animal headcount worldwide is expected to drive growth of the foot and mouth disease vaccine market

High animal density and increasing population of livestock animal is expected to be major impetus for the growth of FMD vaccine market. According to U.S. Department of Agriculture data in 2017, India has cattle in number around 300 million, followed by Brazil and China. According to the factsheet by United Nations Food and Agriculture Organization (UN-FAO), worldwide there is close to one billion headcount of swine. China has highest number of swine headcount numbering 455 million. Infected animals can transmit infection to other animals if their movement is not restricted. Vaccination of animals for FMD prevents future risks and creates sustainable growth for animal population worldwide especially in a region, which are prone to FMD outbreak.

Key players operating foot and mouth disease vaccine market include Indian Immunologicals Ltd., Agrovet, MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogénesis-Bagó S.A, Vetal Animal Health Products S.A.VETAL Animal Health Products, and Vecol S.A.

Foot and Mouth Disease (FMD) is infectious disease, which majorly affects cattle, sheep, goats and swine. It is highly prevalent in regions such as Asia pacific, Latin America, Africa, Middle East and Eastern Europe. Foot and mouth diseases are gaining significant traction due to its economic impact on food industry, as it affects milk and meat production. Therefore, FMD vaccine play important role in the prevention of disease. Both oil-based and aluminum hydroxide adjuvants variety are available. However, oil-based vaccine hold dominant position in the FMD vaccine market

Market Dynamics

Outbreak of the foot and mouth disease and associated economic loses are important driver for the growth of the FMD vaccine market. According to World Organization for Animal Health (OIE), around 23 countries from Asia Pacific, Latin America and Africa reported FMD outbreak in the 2016. According to journal Acta Tropica published in May 2017, prevalence of FMD in Ethiopia ranges from 5.6% to 42.7% in cattle and from 4% to 11% in small ruminant and in 30% in ungulate wildlife. Five of seven serotypes, namely serotype O, A, C, SAT1 and SAT2 are most commonly observed. This hampers animal rearing and trade practice at significant extent. Government initiatives to combat FMD outbreak would be another important driver for growth of FMD vaccine market. In March, 2007, Argentina, Brazil, and Paraguay government committed to intensive vigilance for FMD in a shared zone encompassing a small area along both sides of their common borders. The agreement became effective due to joint evaluation mission by OIE

Key features of the study:

  • This report provides in-depth analysis of the foot and mouth disease vaccine market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global foot and mouth disease vaccine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Indian Immunologicals Ltd., Agrovet, MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogénesis-Bagó S.A, Vetal Animal Health Products, S.A.VETAL Animal Health Products, and Vecol S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation:

Global Foot and Mouth Disease Vaccine Market, By Vaccine Type

  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines

Global Foot and Mouth Disease Vaccine Market, By Animal Type

  • Cattle
  • Sheep and Goat
  • Swine
  • Others

Global Foot and Mouth Disease Vaccine Market, By Geography

  • North America
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Vaccine Type:
      • Conventional Vaccine
      • Aluminum Hydroxide based vaccine
      • Oil based vaccines
      • Emergency Vaccines
    • By Animal Type:
      • Cattle
      • Sheep and Goat
      • Swine
      • Others
    • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Agrovet*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategies
    • India Immunologicals Ltd.
    • Merck Animal Health
    • Shanghai Hile Bio-Pharmaceutical Co., Ltd.
    • Vallee SA
    • Brilliant Bio Pharma Ltd
    • Merial
    • China Animal Husbandry Co., Ltd.
    • Biogénesis-Bagó S.A.
    • Vetal Animal Health Products S.A.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Market Definition and Scope
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Report Description
    • Executive Summary
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • New Product Launches
    • Mergers and Acquisitions
    • Regulatory Scenario
    • Testimonials from Industry Expert
    • PEST Analysis
    • Porters Five Forces model
    • Government Initiative
    • Epidemiology
  4. Global Foot and Mouth Disease Vaccine Market, By Vaccine Type,2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018 – 2026
      • Segment Trends
    • Conventional Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
        • Aluminum Hydroxide Based vaccine
        • Oil based vaccine
    • Emergency Vaccine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  5. Global Foot and Mouth Disease Vaccine Market , By Animal Type, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018 – 2026
      • Segment Trends
    • Cattle
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Sheep and Goat
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Swine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
  6. Global Foot and Mouth Disease Vaccine Market , By Region, 2018 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 – 2026
    • North America
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Vaccine Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Animal Type, 2018 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Market Share Analysis
    • Company Profiles
      • India Immunologicals Ltd.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Agrovet
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Merck Animal Health
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Vallee SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Brilliant Bio Pharma Ltd
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Merial
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • China Animal Husbandry Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Biogénesis-Bagó S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Vetal Animal Health Products S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 35 market data tables and 30 figures on "Foot and Mouth Disease Vaccine Market” - Global forecast to 2026”.

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.